Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

7.38
Delayed Data
As of Jul 28
 -0.03 / -0.40%
Today’s Change
4.08
Today|||52-Week Range
15.01
-12.04%
Year-to-Date
3 Top Biotech Stocks to Buy Now
Jul 25 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close7.41
Today’s open7.48
Day’s range7.23 - 7.48
Volume3,516,614
Average volume (3 months)5,169,509
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-60.19%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book6.84

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-0.73-1.57%
NKTRNektar Therapeutics+0.93+6.13%
BLUEbluebird bio Inc-0.03-0.05%
OPHTOphthotech Corp+0.05+0.08%
Data as of 3:59pm ET, 07/28/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior Vice President-
Quality Operations
Robert Darius
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers

Search for Jobs